Table 3.
Variables | Hospitalisation | Non-hospitalisation | P-value* |
---|---|---|---|
RS | |||
Direct medical expenses (US$) | |||
Mean (SD.) | 3241.7 (3240.4) | 1065.0 (1125.8) | |
Median(p25,p75) | 2437.0 (1670.43407.4) | 859.3 (563.0,1255.6) | < 0.001 |
Medical costs (US$) | |||
Mean (SD.) | 2094.7 (2623.8) | 703.4 (994.9) | |
Median(p25,p75) | 1422.2 (825.92303.7) | 518.5 (296.3959.3) | < 0.001 |
RMR | |||
Direct medical expenses (US$) | |||
Mean (SD.) | 11,739.3 (8984.6) | 2268.1 (2949.9) | |
Median(p25,p75) | 11,133.3 (4996.316174.1) | 1540.7 (488.92440.7) | < 0.001 |
Medical costs (US$) | |||
Mean (SD.) | 8460.0 (9204.2) | 983.7 (971.3) | |
Median(p25,p75) | 4311.1 (2525.912111.1) | 763.0 (92.61825.9) | < 0.001 |
MDR | |||
Direct medical expenses (US$) | |||
Mean (SD.) | 12,559.6 (8252.9) | 1363.0 (1033.6) | |
Median(p25,p75) | 11,348.1 (7103.716874.1) | 1688.9 (511.11888.9) | < 0.001 |
Medical costs (US$) | |||
Mean (SD.) | 9666.3 (8691.5) | 855.6 (1033.3) | |
Median(p25,p75) | 7948.1 (3455.613151.9) | 348.1 (0.0,1533.3) | < 0.001 |
Note: US$: United States dollar
A currency exchange rate of Chinese RMB 675 Yuan to US$ 100 Yuan (at the end of 2017)
RS rifampicin-susceptible
RMR rifampicin-monoresistant
MDR multidrug-resistant
*Mann-Whitney test